Glucose Health Statistics
Total Valuation
Glucose Health has a market cap or net worth of $8.50 million. The enterprise value is $8.30 million.
| Market Cap | 8.50M |
| Enterprise Value | 8.30M |
Important Dates
The last earnings date was Wednesday, February 8, 2023.
| Earnings Date | Feb 8, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
Glucose Health has 17.01 million shares outstanding. The number of shares has increased by 10.40% in one year.
| Shares Outstanding | 17.01M |
| Shares Change (YoY) | +10.40% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 5.11% |
| Owned by Institutions (%) | n/a |
| Float | 8.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.89 |
| Forward PS | n/a |
| PB Ratio | 32.98 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 15.51 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.80, with zero debt.
| Current Ratio | 2.80 |
| Quick Ratio | 1.58 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -163.72% and return on invested capital (ROIC) is -163.72%.
| Return on Equity (ROE) | -163.72% |
| Return on Assets (ROA) | -105.81% |
| Return on Capital (ROIC) | -163.72% |
| Revenue Per Employee | $178,241 |
| Profits Per Employee | -$140,651 |
| Employee Count | 3 |
| Asset Turnover | 1.48 |
| Inventory Turnover | 1.34 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.30% in the last 52 weeks. The beta is 3.48, so Glucose Health's price volatility has been higher than the market average.
| Beta (1Y) | 3.48 |
| 52-Week Price Change | +6.30% |
| 50-Day Moving Average | 0.69 |
| 200-Day Moving Average | 0.37 |
| Relative Strength Index (RSI) | 41.03 |
| Average Volume (30 Days) | 22,608 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Glucose Health had revenue of $534,724 and -$421,953 in losses. Loss per share was -$0.02.
| Revenue | 534,724 |
| Gross Profit | 215,752 |
| Operating Income | -421,950 |
| Pretax Income | -421,953 |
| Net Income | -421,953 |
| EBITDA | -421,950 |
| EBIT | n/a |
| Loss Per Share | -$0.02 |
Balance Sheet
The company has $203,879 in cash and no debt, giving a net cash position of $203,879 or $0.01 per share.
| Cash & Cash Equivalents | 203,879 |
| Total Debt | n/a |
| Net Cash | 203,879 |
| Net Cash Per Share | $0.01 |
| Equity / Book Value | 257,724 |
| Book Value Per Share | 0.02 |
| Working Capital | 254,429 |
Cash Flow
| Operating Cash Flow | -241,576 |
| Capital Expenditures | n/a |
| Free Cash Flow | -241,576 |
| FCF Per Share | -$0.01 |
Margins
Gross margin is 40.35%, with operating and profit margins of -78.91% and -78.91%.
| Gross Margin | 40.35% |
| Operating Margin | -78.91% |
| Pretax Margin | -78.91% |
| Profit Margin | -78.91% |
| EBITDA Margin | -78.91% |
| EBIT Margin | n/a |
| FCF Margin | -45.18% |
Dividends & Yields
Glucose Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.40% |
| Shareholder Yield | -10.40% |
| Earnings Yield | -4.96% |
| FCF Yield | -2.84% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 17, 2014. It was a reverse split with a ratio of 1:50.
| Last Split Date | Nov 17, 2014 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |